Search

Your search keyword '"Johanson, Per"' showing total 263 results

Search Constraints

Start Over You searched for: Author "Johanson, Per" Remove constraint Author: "Johanson, Per"
263 results on '"Johanson, Per"'

Search Results

4. Effect of Dapagliflozin on Outpatient Worsening of Patients With Heart Failure and Reduced Ejection Fraction: A Prespecified Analysis of DAPA-HF

6. Dapagliflozin and Cardiac, Kidney, and Limb Outcomes in Patients With and Without Peripheral Artery Disease in DECLARE-TIMI 58

8. Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus

14. A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes

15. Long‐Term Ticagrelor in Patients With Prior Coronary Stenting in the PEGASUS‐TIMI 54 Trial

20. Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction

22. Clinical Application of High-Sensitivity Troponin Testing in the Atherosclerotic Cardiovascular Disease Framework of the Current Cholesterol Guidelines

25. 'Mirror-lake' serial relationship of Electrocardiographic and biochemical indices for the detection of reperfusion and the predidtion of salvage in patients with acute myocardial infarction

28. Third universal definition of myocardial infarction

29. Continuous ST monitoring: a bedside instrument?

32. Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS‐TIMI 54 Trial

33. Gut Microbiota‐Dependent Trimethylamine N‐oxide and Cardiovascular Outcomes in Patients With Prior Myocardial Infarction: A Nested Case Control Study From the PEGASUS‐TIMI 54 Trial

34. Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes

36. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54

37. A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes.

42. Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS-TIMI 54

43. Efficacy and safety with ticagrelor in patients with prior myocardial infarction in the approved European label: insights from PEGASUS-TIMI 54

44. Improvements in hip arthroplasty - did they work? Evaluations of different articulations and fixation concepts

45. Reduction in Subtypes and Sizes of Myocardial Infarction With Ticagrelor in PEGASUS–TIMI 54

46. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54.

48. Efficacy and Safety of Ticagrelor Over Time in Patients With Prior MI in PEGASUS-TIMI 54

49. Phylogeny of Lungfi shes

Catalog

Books, media, physical & digital resources